Critical role of smad2 in tumor suppression and transforming growth factor-β-Lnduced apoptosis of prostate epithelial cells

Cancer Research

Volumn 69, Issue 6, 2009, Pages 2185-2190

  Yang, Jiayi ^a   Wahdan Alaswad, Reema ^a   Danielpour, David ^a,b  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SHORT HAIRPIN RNA; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; MADH2 PROTEIN, RAT; MADH3 PROTEIN, RAT; SMALL INTERFERING RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER INHIBITION; CARCINOGENICITY; CARCINOMA CELL; CELL GROWTH; CELL LINE; FLOW CYTOMETRY; GENE CONTROL; GENE EXPRESSION; MALE; MOUSE; NONHUMAN; NUDE MOUSE; PHENOTYPE; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROSTATE EPITHELIUM; RAT; STEM CELL; TUMOR GROWTH; WESTERN BLOTTING; ANIMAL; DRUG ANTAGONISM; DRUG EFFECT; GENE SILENCING; GENETIC TRANSDUCTION; GENETICS; LENTIVIRINAE; METABOLISM; PATHOLOGY; PHYSIOLOGY; PROSTATE TUMOR; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; TUMOR CELL LINE; WISTAR RAT;

ANIMALS; APOPTOSIS; CELL LINE, TUMOR; GENE SILENCING; LENTIVIRUS; MALE; MICE; MICE, NUDE; PROSTATIC NEOPLASMS; RATS; RATS, WISTAR; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSCRIPTIONAL ACTIVATION; TRANSDUCTION, GENETIC; TRANSFORMING GROWTH FACTOR BETA;

EID: 65549154497     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-08-3961     Document Type: Article

References (20)

1. Danielpour D. Functions and regulation of transforming growth factor-β (TGF-β) in the prostate. Eur j Cancer 2005;41:846-57.
2. Massague J, Seoane J, Wotton D, Smad transcription factors. Genes Dev 2005;19:2783-810.
3. Derynck R, Zhang YE. Smad-dependent and Smad- independent pathways in TGF-β family signalling. Mature 2003;425:577-84.
4. Yang YC, Piek E, Zavadil J, et al. Hierarchical model of gene regulation by transforming growth factor β, Proc Natl Acad Sci USA 2003;100:10269-74.
5. Brown KA, Pietenpol JA, Moses HL. A tale of two proteins: differential roles and regulation of Smad2 and Smad3 in TGF-f signaling. J Cell Biochem 2007; 101:9-33.
6. Sjohlom T, Jones S, Wood LD, et al. The consensus coding sequences of human breast and colorectal cancers. Science 2006;314:268-74.
7. Levy L, Hill OS. Alterations in components of the TGF-β superfamily signaling pathways in human cancer. Cytokine Growth Factor Rev 2006;17:41-58.
8. Latil A, Pesche S, Valeri A, Fournier G, Cussenot O, Lidereau R. Expression and mutational analysis of the MADR2/Smad2 gene in human prostate cancer. Prostate 1999;40:225-31.
9. Yin Z, Babaian Rj, Troncoso P, et al. Limiting the location of putative human prostate cancer tumor suppressor genes on chromosome 18q. Oncogene 2001; 20:2273-80.
10. Perttu MC, Martikainen PM, Huhtala HSf et al. Altered levels of Smad2 and Smad4 are associated with human prostate carcinogenesis. Prostate Cancer Prostatic Dis 2006;9:185-9.
11. Danielpour D, Kadomateu K, Anzano MA, Smith JM, Sporn MB, Development and characterization of nontumorigenie and tumorigenic epithelial cell lines from rat dorsal-lateral prostate. Cancer Res 1994;54: 3413-21.
12. Hsing AY, Kadomatsu K, Bonham Mj, Danielpour D. Regulation of apoptosis induced by transforming growth factor- β1 in nontumorigenie rat prostatic epithelial cell lines. Cancer Res 1996;56:5146-9.
13. Tang B, de Castro K, Barnes HE, et al. Loss of responsiveness to transforming growth factor β induces malignant transformation of nontumorigenie rat prostate epithelial cells. Cancer Res 1999;59:4834-42.
14. Hayward SW, Haughney PC, Lopes ES, Danielpour D, Cunlia GR. The rat prostatic epithelial cell line NRP-152 can differentiate in vivo in response to its stromal environment. Prostate 1999;39:205-12.
15. Danielpour D. Transdifferentiation of NRP-152 rat prostatic basal epithelial cells toward a luminal phenotype: regulation by glucocorticoid, insulin-like growth factor-1 and transforming growth factor-1. J Cell Sci 1999;112:169-79.
16. Yang J, Song K, Krebs TL, Jackson MW, Danielpour D. Rb/E21;4 and Smad2/3 link survivin to TGF-β-induced apoptosis and tumor progression. Oncogene 2008;27: 5326-38.
17. Wiznerowicz M, Trono D. Conditional suppression of cellular genes: lentivirus vector-mediated drug-inducible RNA interference, J Virol 2003;77:8957-61.
18. Kim SG, Kim HA, Jong HS, et al. The endogenous ratio of Smad2 and Smad3 influences the cytostatic function of Smad3. Mol Biol Cell 2005;16:4672-83.
19. Tian F, DaCosta Byfield S, Parks WT, et al. Reduction in Smad2/3 signaling enhances tumorigenesis but suppresses metastasis of breast cancer cell lines. Cancer Res 2003;63:8284-92.
20. Hoot KE, Lighthall J, Han G, et al. Keratinocyte- specific Smad2 ablation results in increased epithelial- mesenchymal transition during skin cancer formation and progression. J Clin Invest 2008;118:2722-32.